Desenvolvimento e caracterização de nanopartículas contendo meropenem e avaliação da atividade frente à Klebsiella pneumoniae resistente aos carbapenêmicos
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
DOI
Abstract
The World Health Organization (WHO) has declared antimicrobial resistance as one of
the greatest threats to global public health in the 21st century. Consequently, it highlights
the urgent need for research into innovative alternatives, particularly against critical Gramnegative bacteria such as carbapenem-resistant Klebsiella pneumoniae (CRKp). In this
context, nanotechnology emerges as a promising strategy for developing new therapeutic
approaches. Thus, the present study aimed to develop and characterize nanoparticles for
the delivery of meropenem (MRP), with the goal of providing a new therapeutic alternative
against CRKp. Three different formulations containing chitosan (QT), a polymer with
promising antimicrobial activity, were developed: nanoparticles primarily composed of QT
(NPQT), liposomes made of dipalmitoylphosphatidylcholine and cholesterol coated with
QT (LQT), and nanoparticles combining silver, which also has antimicrobial activity, with
QT (AgNPQT). Although NPQT showed results consistent with the literature in terms of
average hydrodynamic diameter (DHm) (100.73 ± 2.71 nm), polydispersity index (PdI)
(0.300 ± 0.02), and zeta potential (ZP) (+26.97 ± 0.21 mV), they exhibited low
encapsulation efficiency (EE) (~3%), precluding further studies. For the liposomes, after
QT coating, we observed an increase in DHm (from 120.79 ± 9.89 nm to 205.46 ± 18.41
nm), maintenance of PdI, and inversion of ZP to a positive value (+27.17 ± 1.36 mV).
Furthermore, EE was higher than that observed for NPQT (~26%). However, in vitro
antibacterial activity results against reference strains of carbapenemase-producing K.
pneumoniae indicated that nanoencapsulation was not effective in reducing the minimum
inhibitory concentration (MIC) compared to free MRP (MIC > 500 µg/mL for both samples).
Finally, the AgNPQT-ME-MRP exhibited DHm = 75.21 ± 6.06 nm, PdI = 0.542 ± 0.02, and
ZP = 41.60 ± 1.13 mV. Additionally, Raman spectroscopy and surface-enhanced Raman
spectroscopy (SERS) analyses corroborated the adsorption of MRP onto the AgNPQT
surface. Morphological characterization of this formulation using Atomic Force Microscopy
revealed spherical particles with sizes consistent with the DHm measurements. Regarding
activity against CRKp, the MIC of AgNPQT-MRP was lower than that of free MRP for all
tested strains (reference and clinical), with a bacteriostatic effect. These results may be
associated with a potential synergistic action between MRP and the nanoparticle
constituents, indicating promising potential for combating carbapenem-resistant bacteria.
Description
Citation
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

